Want to see JP:9267 full AI Analyst Report?
Genky DrugStores Co., Ltd. (9267) Financial Statements
Genky DrugStores Co., Ltd. Financial Overview
Genky DrugStores Co., Ltd.'s market cap is currently $104.38B. The company's EPS TTM is $258.51; its P/E ratio is 13.13; and it has a dividend yield of 0.38%. Genky DrugStores Co., Ltd. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Jun 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 220.64B | $ 200.79B | $ 184.86B | $ 169.06B | $ 154.64B |
| Gross Profit | $ 44.92B | $ 35.09B | $ 32.53B | $ 29.90B | $ 26.68B |
| Operating Income | $ 10.98B | $ 9.66B | $ 9.02B | $ 6.71B | $ 5.68B |
| EBITDA | $ 18.12B | $ 16.41B | $ 14.47B | $ 11.73B | $ 10.73B |
| Net Income | $ 7.88B | $ 7.07B | $ 6.32B | $ 4.76B | $ 4.42B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 7.87B | $ 6.22B | $ 5.90B | $ 5.33B | $ 5.44B |
| Total Assets | $ 145.60B | $ 128.27B | $ 114.84B | $ 106.92B | $ 97.64B |
| Total Debt | $ 39.64B | $ 34.37B | $ 30.65B | $ 32.35B | $ 30.96B |
| Net Debt | $ 31.77B | $ 28.15B | $ 24.75B | $ 27.02B | $ 25.52B |
| Total Liabilities | $ 84.22B | $ 74.84B | $ 68.15B | $ 66.23B | $ 61.40B |
| Stockholders' Equity | $ 61.37B | $ 53.43B | $ 46.68B | $ 40.68B | $ 36.23B |
| Cash Flow | |||||
| Free Cash Flow | $ -3.13B | $ -2.50B | $ 2.98B | $ -1.12B | $ -4.39B |
| Operating Cash Flow | $ 16.98B | $ 12.60B | $ 13.26B | $ 8.77B | $ 6.08B |
| Investing Cash Flow | $ -20.28B | $ -15.62B | $ -10.63B | $ -9.74B | $ -10.59B |
| Financing Cash Flow | $ 4.95B | $ 3.35B | $ -2.06B | $ 854.00M | $ 2.04B |
Currency in JPY